Skip to main content

Table 1 Clinical and demographic data of the analyzed patients (n = 1356)

From: Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients

Age (years) 55.5 ± 13.3
Female gender (%) 85
Disease duration (years) 8.4 ± 8.8
RF positivity (%) 76
RF absolute level (IU/ml) 139.3 ± 196.4
ACPA positivity (%) 72
CRP level (mg/l) 17.7 ± 23.8
DAS28 score 5.00 ± 1.59
Swollen joint count (n) 6.56 ± 5.44
Current MTX therapy (%) 64
MTX therapy ever (%) 92
MTX non-responder (%) 51
current csDMARD therapy (other than MTX) (%) 35
csDMARD therapy ever (other than MTX) (%) 76
Presence of erosions (%) 61
Current smoker (%) 26
Risk of RRP (%) 26.8 ± 13.7
Risk of RRP ≥ 40% (%) (primary endpoint) 18,2